Sign In
Buy SEER
$1.86
-0.0100 (-0.535%)
At Close: Jun 03, 2026
Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer's, Population Health, and Xenotransplantation at HUPO 2024
07:00am, Monday, 21'st Oct 2024
Seer's Proteograph™ Product Suite reveals new insights into Alzheimer's pathways, drives population-scale plasma analysis, and captures immune dynamics in xenotransplantation—with additional break
Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
04:05pm, Thursday, 22'nd Aug 2024
REDWOOD CITY, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the co
Seer Appoints Nicolas Roelofs to its Board of Directors
04:05pm, Wednesday, 14'th Aug 2024
REDWOOD CITY, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it has appo
Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference
07:00am, Friday, 09'th Aug 2024
REDWOOD CITY, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the co
Seer, Inc. (SEER) Reports Q2 Loss, Misses Revenue Estimates
07:20pm, Thursday, 08'th Aug 2024
Seer, Inc. (SEER) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.37 per share a year ago.
Seer to Report Second Quarter 2024 Financial Results on August 8, 2024
04:03pm, Thursday, 18'th Jul 2024
REDWOOD CITY, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it wil
SEER RECEIVES CONTRACT FROM BIOCHAR NOW FOR THE MANUFACTURING OF KILNS AND INTENDS TO OPEN A JV TEXAS BIOCHAR FACILITY
11:05am, Friday, 14'th Jun 2024
SEER's product and manufacturing division, SEM, LLC, receives its first order from Biochar Now for the manufacturing of 33 kilns totaling approximately $600,000
Secretome profiles from SpaceX Inspiration4 mission show alterations in oxidative stress, brain homeostasis, and coagulation
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ's Early Cancer Detection Study
10:55am, Sunday, 02'nd Jun 2024
Combined Workflow of Proteograph™ XT Assay and Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer Robustly Identifies over 13,000 Protein Groups Across a Study of 2,840 Subjects Combined W
Lab Instrument Industry Update - New Commercial Entrants
09:17am, Thursday, 23'rd May 2024
Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry h
Seer, Inc. (SEER) Reports Q1 Loss, Misses Revenue Estimates
07:46pm, Wednesday, 08'th May 2024
Seer, Inc. (SEER) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.38 per share a year ago.
Seer Reports First Quarter 2024 Financial Results
04:05pm, Wednesday, 08'th May 2024
Demonstrated the power of the Proteograph Product Suite with a growing number of customer presentations and publications Demonstrated the power of the Proteograph Product Suite with a growing number o
Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
04:03pm, Wednesday, 08'th May 2024
New Seer Technology Access Center to open in Bonn, Germany Provides life sciences researchers conducting proteomic studies full-service access to the Seer Proteograph™ Product Suite and mass spectro
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
04:05pm, Tuesday, 23'rd Apr 2024
REDWOOD CITY, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it wi
Seer, Inc. (SEER) Q4 2023 Earnings Call Transcript
07:12am, Friday, 01'st Mar 2024
Seer, Inc. (SEER) Q4 2023 Earnings Call Transcript
